Pulmonary diseases and the liver
Rajan Kochar1, Michael B Fallon
1Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 4.234, Houston, TX 77030, USA.
Clinics in Liver Disease
|November 30, 2010
Summary
This review examines liver complications arising from primary lung diseases like cystic fibrosis and tuberculosis. It highlights less-discussed hepatobiliary issues in respiratory failure patients.
Area of Science:
- Pulmonology
- Hepatology
- Internal Medicine
Background:
- Chronic liver disease frequently causes pulmonary issues such as hepatopulmonary syndrome.
- Pulmonary diseases, conversely, can lead to significant hepatobiliary complications, which are less understood.
- Existing reviews primarily focus on liver disease's impact on the lungs.
Purpose of the Study:
- To review the hepatobiliary manifestations of primary pulmonary diseases.
- To focus on complications arising from respiratory failure, cystic fibrosis, alpha-1 antitrypsin deficiency, sarcoidosis, and tuberculosis.
Main Methods:
- Literature review of primary pulmonary diseases and their impact on the liver.
- Synthesis of existing research on hepatobiliary complications in specific respiratory conditions.
Main Results:
- Respiratory failure, cystic fibrosis, alpha-1 antitrypsin deficiency, sarcoidosis, and tuberculosis are associated with distinct hepatobiliary complications.
- These complications are often overlooked compared to pulmonary issues in liver disease.
Conclusions:
- Understanding hepatobiliary complications of lung diseases is crucial for comprehensive patient care.
- Further research is needed to elucidate the mechanisms and management of these conditions.
More Related Videos
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation